Navigation Links
Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO,Annual Meeting

s, especially cancer patients, throughout the world.

About Eisai Inc.

Eisai Inc. is a U.S. pharmaceutical subsidiary of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: neurology, gastrointestinal disorders and oncology/critical care. Established in 1995 and ranked among the top-20 U.S. pharmaceutical companies (based on retail sales), Eisai Inc. began marketing its first product in the United States in 1997 and has rapidly grown to become an integrated pharmaceutical business with sales of approximately $2.6 billion in fiscal year 2006 (year ended March 31, 2007).

Eisai Inc. employs approximately 1,500 people at its headquarters in Woodcliff Lake, NJ, at its state-of-the-art pharmaceutical production and formulation research and development facility in Research Triangle Park, NC, and in the field. For more information about Eisai, please visit http://www.eisai.com.

About Eisai Medical Research Inc.

Eisai Medical Research Inc., a U.S. pharmaceutical subsidiary of Eisai Co., Ltd., headquartered in Ridgefield Park, NJ, is focused on clinical drug development of new chemical entities and of new indications for marketed products.

About Morphotek, Inc.

Morphotek(R), Inc., a U.S. subsidiary of Eisai Co., Ltd., was acquired by Eisai in April 2007. Founded in 2000 and located in Exton, PA, Morphotek is a biopharmaceutical company which discovers and develops monoclonal antibodies through the use of proprietary human antibody technology called Human MORPHODOMA(R). Morphotek has assembled a strong pipeline of lead products in the areas of oncology and inflammation and infectious diseases. It has programs in clinical development and in preclinical stage moving towards IND filing. For further information, visit




Page: 1 2 3 4

Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
Post Your Comments:
(Date:12/1/2008)...ll/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ...world,s leading medical journals, results of clini...imental compound tasimelteon (VEC-162). The publi...in agonist tasimelteon (VEC-162) for transient ins...olled multicentre trials." Results are reported fr...
(Date:12/1/2008)...wo-way switch that, if turned off, causes lymphati...y lose their identity and become more like blood e... Scientists at St. Jud...t a certain differentiated cell type is so ready t...t expression of a gene called Prox1 to dissuade ...
(Date:12/1/2008)...GeoVax Labs, Inc.,(OTC Bulletin Board: GOVX), an ...man vaccines for diseases caused by HIV-1 (Human I...s, announced today that the launch of its Phase 2a...ites across North and South America.,These trials...Institutes of,Health (NIH), and the HIV Vaccine T...
(Date:11/28/2008)...l/ -- Eli Lilly and Company,(NYSE: LLY ) has wi...A) from,the U.S. Food and Drug Administration (FD...ement of chronic pain. Lilly plans to resubmit the...ta from a recently completed positive study,in ch...e decision does not affect duloxetine,s FDA-approv...
Breaking Medicine Technology:Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Gilead to Topple GSK as the Top Player in the Anti Infectives Drug Market in 2014 9132 1Gilead to Topple GSK as the Top Player in the Anti Infectives Drug Market in 2014 9132 2Gilead to Topple GSK as the Top Player in the Anti Infectives Drug Market in 2014 9132 3Forterus Inc Announces Stock Buyback 29598 1Forterus Inc Announces Stock Buyback 29598 2The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance 29596 1The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance 29596 2The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance 29596 3The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance 29596 4Innovative Wellness Project Launched in Four Maine School Districts 29592 1Innovative Wellness Project Launched in Four Maine School Districts 29592 2
(Date:12/2/2008)...ies, the problem with the holidays is family. Eld...ow caregivers of aging parents can bring the joy o... , San Mateo, CA (PRWEB) ...f the holiday season is family, especially aging p...er Koch , founder of Encore Management , has a si...
(Date:12/2/2008)...rofit Launches Age-related Macular Degeneration Ca...ible Patients and Free Eye-Healthy Cookbooks , ...cember 2, 2008 -- "Do You See What I See?&quo...n as Age-related Macular Degeneration (AMD) the an...his…. a large black hole in the center of y...
(Date:12/2/2008)...nnounces that the SouthEast Alaska Regional Health...ed the Rhapsody™ Integration Engine to help ... pharmacy, laboratory and business programs commun...nectivity to statewide systems such as VacTrAK (th...S (an MIS and clinical documentation tool used by ...
(Date:12/2/2008)... Provides Online Resource and Fire Safety Tips for... Boston, MA (PRWEB) December 2, 2008 -...eete , actress, philanthropist and mother of four,... a few moments before the holiday rush to review f...eSmart.com. , , , , ,Home fires top the list of A...
Breaking Medicine News(10 mins):Health News:Holidays with Aging Parents: Elder Care Expert Has the Prescription for Caregiver Stress 2Health News:Holidays with Aging Parents: Elder Care Expert Has the Prescription for Caregiver Stress 3Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 2Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 3Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 2Health News:SouthEast Alaska Regional Health Consortium Selects Orion Health's Rhapsody Integration Engine for Full-scale Application Integration and Monitoring 3Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 2Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 3Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 4
...A.P.J. Abdul Kalam Friday called for taking advant...ostic tool and of tele-radiology to help the needy...s speaking during a visit to the digital radiology...f India Limited (ECIL), which is working towards p...
...eshs Gorakhpur District are grappling to fight aga...is , that has killed at least 30 children in the p... Department, B.R.D Medical College, said that the ...ived over 100 patients since January out of whom 3...
...ay we interviewed a doctor - Dr.Makani Hemadri, wh...rrent problems facing the doctor community at lar...of healthcare systems in the world. Apparently alm...onal Health Service of England. In the US, Middle-...
Healthcare in India is presently the cynosure of global attention. A country that churns the highest number of medical brains, is also recording excellence in healthcare services. It is no longer wis
Other Medicine News:Health News:Interview With a Surgeon Hidden Hero of the NHS 2Health News:Interview With a Surgeon Hidden Hero of the NHS 3Health News:Interview With a Surgeon Hidden Hero of the NHS 4Health News:Interview With a Surgeon Hidden Hero of the NHS 5Health News:Interview With a Surgeon Hidden Hero of the NHS 6Health News:Interview With a Surgeon Hidden Hero of the NHS 7Health News:Interview With a Surgeon Hidden Hero of the NHS 8Health News:Lets Care For Our Physicians A Salute to Them on Doctors Day! 2Health News:Lets Care For Our Physicians A Salute to Them on Doctors Day! 3
Product includes all 15 Lexi-Comps databases. Includes Lexi-drugs, the official reference of the American Pharmacists Association and the National Professional Society of Pharmacists.
...fety Knife with BD Xstar Blade includes a speciall...tects the blade in prodedure and handling. The Xs...ess for manufacturing surgical blades. This propr...nsistency. The arch style, single-bevel geometry ...
Electric high speed system.
The Durafuge 100 spins swing-out rotors at 4000 rpm and fixed-angle rotors at up to 6300 rpm.
Medicine Products: